Pancreatic Cancer Research

ResearcherAmsterdam University Medical CentersActive in the last 2 years

Eline S. Zwart

ORCID-verified (high confidence, 0.95), identity_conf@1As of 7 November 2026

Matched on ORCID iD 0000-0002-2121-8039; OpenAlex author ID A5057668561. Sources: OpenAlex.

Their work

Papers
9 (first author 4, last author 0)
Trials
0
Grants
0
Labs led
0
Collaborators
35
Papers, trials and grants by year

2019: 1 paper · 2020: 1 paper · 2021: none · 2022: 2 papers · 2023: 2 papers · 2024: 2 papers · 2025: none · 2026: 1 paper

Papers 9

  1. Upfront surgery vs. neoadjuvant therapy in pancreatic cancer with venous involvement: a multicenter retrospective analysis. First author DOI 10.1007/s00423-026-04291-0↗
  2. Margin clearance greater than 1 mm in nodal-positive pancreatic adenocarcinoma patients: multicentre retrospective analysis. First author DOI 10.1093/bjsopen/zrae076↗
  3. In-depth immune profiling of peripheral blood mononuclear cells in patients with pancreatic ductal adenocarcinoma reveals discriminative immune subpopulations. First author DOI 10.1111/cas.16147↗
  4. Spatial immune composition of tumor microenvironment in patients with pancreatic cancer. Co-author DOI 10.1007/s00262-023-03573-6↗
  5. The immune microenvironment after neoadjuvant therapy compared to upfront surgery in patients with pancreatic cancer. Co-author DOI 10.1007/s00432-023-05219-7↗
  6. Venous resection for pancreatic cancer, a safe and feasible option? A systematic review and meta-analysis. Co-author DOI 10.1016/j.pan.2022.05.001↗
  7. The Diagnostic Value of the CA19-9 and Bilirubin Ratio in Patients with Pancreatic Cancer, Distal Bile Duct Cancer and Benign Periampullary Diseases, a Novel A… Co-author DOI 10.3390/cancers14020344↗
  8. In the Era of the Leeds Protocol: A Systematic Review and A Meta-Analysis on the Effect of Resection Margins on Survival Among Pancreatic Ductal Adenocarcinoma… Co-author DOI 10.1177/1457496920911807↗
  9. Tumor microbiome: Pancreatic cancer and duodenal fluids contain multitudes, …but do they contradict themselves? First author DOI 10.1016/j.critrevonc.2019.102824↗

Closest collaborators

The 25 strongest of 35 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Geert Kazemier M · 6 shared papers, 2019–2026 · strength 0.98
  2. Laura L. Meijer · 5 shared papers, 2019–2024 · strength 0.76
  3. Benediktas Kurlinkus · 4 shared papers, 2020–2026 · strength 0.72
  4. Asif Halimi · 4 shared papers, 2020–2026 · strength 0.72
  5. Johanna Laukkarinen · 4 shared papers, 2020–2026 · strength 0.72
  6. Reea Ahola · 4 shared papers, 2020–2026 · strength 0.72
  7. Guralp Onur Ceyhan · 4 shared papers, 2020–2026 · strength 0.72
  8. Yvette van Kooyk · 3 shared papers, 2023–2024 · strength 0.52
  9. Lenka N.C. Boyd · 3 shared papers, 2022–2024 · strength 0.49
  10. Elisa Giovannetti · 3 shared papers, 2019–2024 · strength 0.42
  11. Giulio Belfiori · 2 shared papers, 2024–2026 · strength 0.42
  12. Patrick Maisonneuve · 2 shared papers, 2024–2026 · strength 0.42
  13. Keith John Roberts · 2 shared papers, 2024–2026 · strength 0.42
  14. Ernesto Rodríguez · 2 shared papers, 2023–2024 · strength 0.35
  15. Tessa Y. S. Le Large · 2 shared papers, 2022–2024 · strength 0.32
  16. Giuseppe Malleo · 1 shared paper, 2026 · strength 0.22
  17. Marco Del Chiaro · 1 shared paper, 2026 · strength 0.22
  18. Francesco Giovinazzo · 1 shared paper, 2026 · strength 0.22
  19. Laura Maggino · 1 shared paper, 2026 · strength 0.22
  20. Ernesto Sparrelid · 1 shared paper, 2026 · strength 0.22
  21. Elena B. Rangelova · 1 shared paper, 2026 · strength 0.22
  22. Gabriella Lionetto · 1 shared paper, 2026 · strength 0.22
  23. Massimo Falconi · 1 shared paper, 2026 · strength 0.22
  24. Stefano Crippa · 1 shared paper, 2026 · strength 0.22
  25. Roberto Salvia · 1 shared paper, 2026 · strength 0.22

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.